Shares News

Stellantis is a multinational carmaker due to report Q1 2026 results on 30 April, after announcing a five-year AI collaboration with Microsoft on 16 April 2026. Explore third-party STLAM price targets and technical analysis. Past performance is not a reliable indicator of future results.

Tesla is an electric vehicle and energy company whose shares came under pressure after Q1 2026 earnings showed an EPS beat, weaker-than-expected deliveries and updates on FSD and Robotaxi plans. Explore third-party TSLA price targets. Past performance is not a reliable indicator of future results.

NVIDIA is a US semiconductor company whose recent share-price move has coincided with strong AI spending expectations and continued focus on its OpenAI partnership. Explore third-party NVDA price targets and technical analysis. Past performance is not a reliable indicator of future results.

BioNTech is a German biotech company whose shares have faced pressure since March 2026 amid planned leadership changes, weaker-than-expected revenue guidance, and broader tariff-related uncertainty. Past performance is not a reliable indicator of future results. Read third-party BNTX price targets.

Allianz is a German insurer and asset manager that reported record 2025 operating profit of €17.4bn and launched a €2.5bn share buyback, while its 2026 guidance missed analyst forecasts. Past performance is not a reliable indicator of future results. Explore third-party ALV price targets.

Siemens is a German industrial group whose shares have been supported by stronger Q1 results, higher 2026 EPS guidance, and recent progress in its rail and infrastructure businesses. Past performance is not a reliable indicator of future results. Explore third-party SIE price targets.

Technicals are flashing green in the key time frames, and in sentiment CoT speculators remain net long while retail traders are majority short.

Bayer is a German life sciences company whose 2026 outlook centres on reaffirmed guidance, ongoing Roundup litigation, and the potential effect of US pharmaceutical tariffs. Past performance is not a reliable indicator of future results. Explore third-party BAYN price targets and technical analysis.

Novo Nordisk is a Danish pharmaceutical company whose 2026 outlook has come under pressure from weaker sales guidance, rising GLP-1 competition, and recent US pricing and tariff developments. Past performance is not a reliable indicator of future results. Explore third-party NVO price targets.

Airbus is a European aerospace group whose shares remain sensitive to trade policy, analyst rating changes, and shareholder decisions ahead of its 14 April 2026 AGM. Past performance is not a reliable indicator of future results. Explore third-party AIR price targets and technical analysis.